Zamifenacinfumarate
|
|
|
- CAS號:
- 127308-98-9
- 英文名:
- Zamifenacinfumarate
- 英文別名:
- UK-76654 fumarate;Zamifenacinfumarate;Zamifenacin fumarate, 10 mM in DMSO;Zamifenacin fumarate, M3 receptor antagonist;(3R)-1-[2-(1-,3-Benzodioxol-5-yl)ethyl]-3-(diphenylmethoxy)piperidinefumarate;(R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate;gut,UK 76654,bowel,inhibit,Inhibitor,Muscarinic acetylcholine receptor,UK-76654,muscarinic,mAChR,motility,syndrome,irritable,Zamifenacin fumarate,Zamifenacin,UK76654,colonic
- 中文名:
- Zamifenacinfumarate
- 中文別名:
- 扎非那星富馬酸鹽;扎非那新延胡索酸酯;化合物 T13385;扎非那星富馬酸鹽,10 MM DMSO 溶液;ZAMIFENACIN FUMARATE,M3 RECEPTOR拮抗劑;(R)-3-(苯甲酰氧基)-1-(2-(苯并[D][1,3]二氧雜環(huán)戊烯-5-基)乙基)哌啶富馬酸鹽
- CBNumber:
- CB81075168
- 分子式:
- C31H33NO7
- 分子量:
- 531.61
- MOL File:
- 127308-98-9.mol
|
|
|
Zamifenacinfumarate化學(xué)性質(zhì)
-
儲存條件:
-
Inert atmosphere,2-8°C
-
|
-
溶解度:
-
Soluble to 100 mM in DMSO and to 25 mM in ethanol
-
|
-
形態(tài):
-
Powder
-
|
-
顏色:
-
White to off-white
-
|
Zamifenacinfumarate性質(zhì)、用途與生產(chǎn)工藝
Zamifenacin fumarate (UK-76654 fumarate) 是一種有效的腸道選擇性毒蕈堿 M3 受體拮抗劑。Zamifenacin 可顯著降低腸易激綜合癥的結(jié)腸蠕動。
Zamifenacin exhibits moderate oral bioavailability (mouse 26%, rat 64%, dog 100%) and C
max
(mouse 92, rat 905, dog 416 ng/mL) following oral administration (mouse 13.2, rat 20 and, dog 5 mg/kg).
Zamifenacin exhibits terminal elimination half-lives (mouse 2.1, rat 6.0 and, dog 1.1 h) due to high plasma clearance (68, 35, and 39 mL/min/kg respectively combined with large volumes of distribution (12.5, 19.0, and 3.5 L/kg respectively) following intravenous administration (mouse 5.3, rat 5.0 and, dog 1.0 mg/kg).
|
Animal Model:
|
Male CDl mice (mean weight 23 g)
|
|
Dosage:
|
5.3 mg/kg for i.v.; 13.2 mg/kg for oral (Pharmacokinetic Analysis)
|
|
Administration:
|
Intravenous administration and oral administration
|
|
Result:
|
Oral bioavailability (26%), C
max
(92 ng/mL), T
1/2
(1.1 h).
|
|
Animal Model:
|
Male and female CD rats (mean weight 210 g)
|
|
Dosage:
|
5.0 mg/kg for i.v.; 20 mg/kg for oral (Pharmacokinetic Analysis)
|
|
Administration:
|
Intravenous administration and oral administration
|
|
Result:
|
Oral bioavailability (64%), C
max
(905 ng/mL), T
1/2
(6.0 h).
|
|
Animal Model:
|
Male and two female beagle dogs (13-16 kg)
|
|
Dosage:
|
1.0 mg/kg for i.v.; 5 mg/kg for oral (Pharmacokinetic Analysis)
|
|
Administration:
|
Intravenous administration and oral administration
|
|
Result:
|
Oral bioavailability (100%), C
max
(416 ng/mL), T
1/2
(1.1 h).
|
Zamifenacinfumarate
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
|---|
| 2025/02/08 | HY-107649 | Zamifenacinfumarate
Zamifenacin fumarate | 127308-98-9 | 5mg | 1000元 |
| 2025/02/08 | HY-107649 | Zamifenacinfumarate
Zamifenacin fumarate | 127308-98-9 | 10mM * 1mLin DMSO | 1170元 |
Zamifenacinfumarate
生產(chǎn)廠家
127308-98-9, Zamifenacinfumarate 相關(guān)搜索:
- 抑制劑
- C27H29NO3C4H4O4
- 扎非那星富馬酸鹽,10 MM DMSO 溶液
- ZAMIFENACIN FUMARATE,M3 RECEPTOR拮抗劑
- 化合物 T13385
- (R)-3-(苯甲酰氧基)-1-(2-(苯并[D][1,3]二氧雜環(huán)戊烯-5-基)乙基)哌啶富馬酸鹽
- 扎非那新延胡索酸酯
- 扎非那星富馬酸鹽
- 127308-98-9
- Zamifenacin fumarate, 10 mM in DMSO
- Zamifenacin fumarate, M3 receptor antagonist
- gut,UK 76654,bowel,inhibit,Inhibitor,Muscarinic acetylcholine receptor,UK-76654,muscarinic,mAChR,motility,syndrome,irritable,Zamifenacin fumarate,Zamifenacin,UK76654,colonic
- (R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate
- UK-76654 fumarate
- (3R)-1-[2-(1-,3-Benzodioxol-5-yl)ethyl]-3-(diphenylmethoxy)piperidinefumarate
- Zamifenacinfumarate